Literature DB >> 11601507

Multisystem disorder associated with a missense mutation in the mitochondrial cytochrome b gene.

F Wibrand1, K Ravn, M Schwartz, T Rosenberg, N Horn, J Vissing.   

Abstract

Mitochondrial cytochrome b mutations have been reported to have a homogenous phenotype of pure exercise intolerance. We describe a novel mutation in the cytochrome b gene of mitochondrial DNA (A15579G) associated with a selective decrease of muscle complex III activity in a patient who, besides severe exercise intolerance, also has multisystem manifestations (deafness, mental retardation, retinitis pigmentosa, cataract, growth retardation, epilepsy). The point mutation is heteroplasmic in muscle (88%) and leukocytes (15%), and changes a highly conserved tyrosine to cysteine at amino acid position 278.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601507     DOI: 10.1002/ana.1224

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

Review 1.  Multisystem manifestations of mitochondrial disorders.

Authors:  Stefano Di Donato
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

2.  31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.

Authors:  Tina Dysgaard Jeppesen; Bjørn Quistorff; Flemming Wibrand; John Vissing
Journal:  J Neurol       Date:  2007-02-04       Impact factor: 4.849

Review 3.  Molecular mechanisms of superoxide production by complex III: a bacterial versus human mitochondrial comparative case study.

Authors:  Pascal Lanciano; Bahia Khalfaoui-Hassani; Nur Selamoglu; Anna Ghelli; Michela Rugolo; Fevzi Daldal
Journal:  Biochim Biophys Acta       Date:  2013-03-28

4.  The cytochrome b p.278Y>C mutation causative of a multisystem disorder enhances superoxide production and alters supramolecular interactions of respiratory chain complexes.

Authors:  Anna Ghelli; Concetta V Tropeano; Maria Antonietta Calvaruso; Alessandra Marchesini; Luisa Iommarini; Anna Maria Porcelli; Claudia Zanna; Vera De Nardo; Andrea Martinuzzi; Flemming Wibrand; John Vissing; Ivana Kurelac; Giuseppe Gasparre; Nur Selamoglu; Fevzi Daldal; Michela Rugolo
Journal:  Hum Mol Genet       Date:  2013-02-14       Impact factor: 6.150

5.  Loss of a conserved tyrosine residue of cytochrome b induces reactive oxygen species production by cytochrome bc1.

Authors:  Dong-Woo Lee; Nur Selamoglu; Pascal Lanciano; Jason W Cooley; Isaac Forquer; David M Kramer; Fevzi Daldal
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

6.  A novel mutation in the mitochondrial DNA cytochrome b gene (MTCYB) in a patient with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes syndrome.

Authors:  Valentina Emmanuele; Evangelia Sotiriou; Purificación Gutierrez Rios; Jaya Ganesh; Rebecca Ichord; A Reghan Foley; H Orhan Akman; Salvatore Dimauro
Journal:  J Child Neurol       Date:  2012-05-25       Impact factor: 1.987

Review 7.  The mechanism of ubihydroquinone oxidation at the Qo-site of the cytochrome bc1 complex.

Authors:  Antony R Crofts; Sangjin Hong; Charles Wilson; Rodney Burton; Doreen Victoria; Chris Harrison; Klaus Schulten
Journal:  Biochim Biophys Acta       Date:  2013-02-08

8.  Role of the -PEWY-glutamate in catalysis at the Q(o)-site of the Cyt bc(1) complex.

Authors:  Doreen Victoria; Rodney Burton; Antony R Crofts
Journal:  Biochim Biophys Acta       Date:  2012-11-01

9.  GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L.

Authors:  Ilona Visapää; Vineta Fellman; Jouni Vesa; Ayan Dasvarma; Jenna L Hutton; Vijay Kumar; Gregory S Payne; Marja Makarow; Rudy Van Coster; Robert W Taylor; Douglass M Turnbull; Anu Suomalainen; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2002-09-05       Impact factor: 11.025

10.  Impact of the mitochondrial genetic background in complex III deficiency.

Authors:  Mari Carmen Gil Borlado; David Moreno Lastres; Maritza Gonzalez Hoyuela; Maria Moran; Alberto Blazquez; Rosa Pello; Lorena Marin Buera; Toni Gabaldon; Juan Jose Garcia Peñas; Miguel A Martín; Joaquin Arenas; Cristina Ugalde
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.